User profiles for David Hillus

David Hillus

Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin …
Verified email at charite.de
Cited by 1730

[HTML][HTML] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

H Gruell, K Vanshylla, P Tober-Lau, D Hillus… - Nature medicine, 2022 - nature.com
The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections across the
globe. This new variant of concern carries an unusually high number of mutations in key …

Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021

…, R Helbok, ME Hellemons, D Hillus… - Jama, 2022 - jamanetwork.com
Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort …

D Hillus, T Schwarz, P Tober-Lau… - The Lancet …, 2021 - thelancet.com
Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …

[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19

…, I Wirsching, C Wollboldt, Y Wu, G Schwanitz, D Hillus… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

[HTML][HTML] A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021

…, R Helbok, ME Hellemons, D Hillus… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Objective: To estimate by country and territory of the number of patients affected by long
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …

[HTML][HTML] Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers

…, T Schwarz, K Vanshylla, D Hillus… - The Lancet …, 2021 - thelancet.com
Health-care workers were enrolled at Charité-Universitätsmedizin Berlin (n= 107) and older
people were enrolled at an assisted living facility in Berlin, Germany (n= 82).(A) Anti-S1 IgG …

[PDF][PDF] Complement activation induces excessive T cell cytotoxicity in severe COVID-19

…, M Barone, P Tober-Lau, ET Helbig, D Hillus… - Cell, 2022 - cell.com
Severe COVID-19 is linked to both dysfunctional immune response and unrestrained
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …

[HTML][HTML] Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany

T Schwarz, P Tober-Lau, D Hillus… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…

[HTML][HTML] Immunogenicity of COVID-19 tozinameran vaccination in patients on chronic dialysis

E Schrezenmeier, L Bergfeld, D Hillus… - Frontiers in …, 2021 - frontiersin.org
Patients with kidney failure have notoriously weak responses to common vaccines. Thus,
immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine …

Neutralisation sensitivity of the SARS-CoV-2 omicron BA. 2.75 sublineage

H Gruell, K Vanshylla, P Tober-Lau, D Hillus… - The Lancet Infectious …, 2022 - thelancet.com
6 Sheward DJ, Kim C, Fischbach J, et al. Evasion of neutralising antibodies by omicron
sublineage BA. 2.75. Lancet Infect Dis 2022; published online Sept 1. https://doi. org/10.1016/…